Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s
And so, another working week will soon come to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal
Imminent Need for Funding Addressed: Clearmind Medicine Inc.’s announcement of successful capital raising closely aligns with TDR’s earlier analysis, which identified the company’s urgent need
This Issue is a relatively long one, as it’s something of a catch-up for the holiday period. We look at psychedelic drug development news from
What You Should Know: – In a move aimed at alleviating Arizona’s critical shortage of healthcare providers, Spectrum Healthcare, one of the state’s largest non-profit
Share this article Emergent has several contracts with US government agencies for vaccines and therapeutics for various infectious diseases. Image Credit: Africa Studio / Shutterstock.
Share this article Santhera’s chief medical officer Shabir Hasham said the company is planning on making Agamree available in the UK in the second half
Republican presidential hopeful Nikki Haley will learn how her campaign is resonating with voters after the Jan. 15 Iowa caucuses, the first presidential nominating contest
Share this article Vtama gained FDA approval in 2022 to treat plaque psoriasis and generated $28m for the fiscal year ending 31 March 2023. Credit:
Researchers evaluated trends in substance use and cardiovascular disease-related mortality in the United States using Centers for Disease Control and Prevention data.